摘要
目的探讨艾普拉唑+阿莫西林+左氧氟沙星1周疗法根除幽门螺杆菌(HP)的疗效及安全性。方法选择91例HP阳性消化性溃疡患者,随机分为2组。治疗组采用艾普拉唑(5 mg,2次/d)+阿莫西林(1 000 mg,2次/d)+左氧氟沙星(200 mg,2次/d)联合治疗。对照组采用艾普拉唑(5 mg,2次/d)+阿莫西林(1 000 mg,2次/d)+甲硝唑(400 mg,2次/d)联合治疗。两组治疗7 d后继续用艾普拉唑5 mg,1次/d,共3周。疗程结束4周后复查胃镜和HP,观察HP根除率、症状缓解率、溃疡愈合率和不良反应。结果治疗组和对照组的HP根除率分别为91.3%、73.3%(P<0.05),治疗组和对照组症状缓解率、溃疡愈合率和不良反应发生率分别为8.7%vs.6.7%、89.1%vs.84.4%、19.7%vs.17.8%,两组比较,差异均无统计学意义(P>0.05)。结论艾普拉唑+阿莫西林+左氧氟沙星三联1周疗法是根除HP的理想方案。
Objective To discuss the efficacy and safety of triple therapy of ilaprazole, amoxicillin and levo-floxacin on Helicobacter pylori (Hp) eradication. Methods 91 patients with Hp infection suffering from peptic ulcer were randomized to treatment group and control group. The treatment group were administered ilaprazole ( 5 mg, twice daily) + amoxicillin (1 000 mg, twice daily) + levofloxacin( 200 mg, twice daily)for a week. The control group were administered ilaprazole(5 rag,twice daily) + amoxicillin( 1 000 mg,twice daily) + metronidazole(400 mg,twice dai-ly) for a week. All patients were treated with ilaprazole ( 5 mg, once daily ) for another 3 weeks. The Hp eradication, symptoms, peptic ulcer healing and side-effects were observed after 4 weeks. Results The Hp eradication rate of treat- ment group and control group were 91.3 % and 73.3 % respectively (P 〈 0. 05 ). The symptom ameliorate rate, peptic ulcer healing rate and side-effect rate of treatment group and control group were g. 7 % vs. 6.7% (P 〉0.05) ,89.1% vs. 84.4 % ( P 〉 0. 05 ), 19. 7 % vs. 17.8 % ( P 〉 0. 05 ), respectively. Conclusion The triple therapy of ilaprazole, amoxicillin and levofloxacin( 1 week)is ideal for Hp eradication.
出处
《实用药物与临床》
CAS
2013年第1期24-25,共2页
Practical Pharmacy and Clinical Remedies